EyePoint, Inc. (EYPT)
3.25
+0.02
(+0.62%)
USD |
NASDAQ |
Oct 02, 16:00
3.25
0.00 (0.00%)
After-Hours: 20:00
EyePoint Gross Profit Margin (Quarterly) : -36.09% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -36.09% |
| March 31, 2026 | -67.24% |
| December 31, 2025 | -16.77% |
| September 30, 2025 | 25.36% |
| June 30, 2025 | 86.82% |
| March 31, 2025 | 96.71% |
| December 31, 2024 | 92.96% |
| September 30, 2024 | 93.01% |
| June 30, 2024 | 85.22% |
| March 31, 2024 | 93.50% |
| December 31, 2023 | 92.89% |
| September 30, 2023 | 92.09% |
| June 30, 2023 | 80.32% |
| March 31, 2023 | 91.67% |
| December 31, 2022 | 65.68% |
| September 30, 2022 | 79.82% |
| June 30, 2022 | 79.69% |
| March 31, 2022 | 74.26% |
| December 31, 2021 | 68.40% |
| September 30, 2021 | 73.07% |
| June 30, 2021 | 71.77% |
| March 31, 2021 | 72.62% |
| December 31, 2020 | 56.86% |
| September 30, 2020 | 84.09% |
| June 30, 2020 | 72.90% |
| Date | Value |
|---|---|
| March 31, 2020 | 78.70% |
| December 31, 2019 | 77.54% |
| September 30, 2019 | 62.46% |
| June 30, 2019 | 81.68% |
| March 31, 2019 | 53.03% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| June 30, 2017 | 69.47% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
| December 31, 2013 | 0.00% |
| September 30, 2013 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 85.08% |
| Eli Lilly & Co. | 85.78% |
| Elanco Animal Health, Inc. | 48.17% |
| Amylyx Pharmaceuticals, Inc. | -- |
| Nuvation Bio, Inc. | 68.42% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -133.4% |
| Return on Assets | -107.0% |
| Return on Invested Capital | -121.5% |
| Profit Margin (Quarterly) | -18.63K% |
| Operating Margin (Quarterly) | -19.21K% |
| Return on Net Operating Assets | -695.3% |